SGAM
EBS icon

Smith Group Asset Management’s Emergent Biosolutions EBS Stock Holding History

Smith Group Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50
Closed -$3K – 376
2021
Q2 		$3K Hold
50
– – ﹤0.01% 352
2021
Q1 		$5K Sell
50
-1,390
-97% -$142K ﹤0.01% 307
2020
Q4 		$129K Sell
1,440
-10
-0.7% -$918 0.01% 199
2020
Q3 		$150K Sell
1,450
-310
-18% -$33.4K 0.01% 183
2020
Q2 		$139K Sell
1,760
-30
-2% -$2.24K 0.01% 182
2020
Q1 		$104K Hold
1,790
– – 0.01% 212
2019
Q4 		$97K Hold
1,790
– – ﹤0.01% 240
2019
Q3 		$94K Buy
1,790
+320
+22% +$14.9K ﹤0.01% 243
2019
Q2 		$71K Sell
1,470
-220
-13% -$10.5K ﹤0.01% 256
2019
Q1 		$85K Sell
1,690
-4,584
-73% -$270K ﹤0.01% 269
2018
Q4 		$372K Sell
6,274
-103
-2% -$6.64K 0.01% 205
2018
Q3 		$420K Buy
6,377
+5,970
+1,467% +$348K 0.01% 204
2018
Q2 		$21K Buy
407
+25
+7% +$1.3K ﹤0.01% 384
2018
Q1 		$20K Hold
382
– – ﹤0.01% 395
2017
Q4 		$18K Hold
382
– – ﹤0.01% 405
2017
Q3 		$15K Hold
382
– – ﹤0.01% 414
2017
Q2 		$13K Hold
382
– – ﹤0.01% 419
2017
Q1 		$11K Hold
382
– – ﹤0.01% 404
2016
Q4 		$13K Hold
382
– – ﹤0.01% 404
2016
Q3 		$12K Sell
382
-7,010
-95% -$204K ﹤0.01% 406
2016
Q2 		$208K Buy
7,392
+7,010
+1,835% +$275K 0.01% 249
2016
Q1 		$14K Sell
382
-20
-5% -$706 ﹤0.01% 383
2015
Q4 		$16K Sell
402
-3
-0.7% -$105 ﹤0.01% 404
2015
Q3 		$12K Hold
405
– – ﹤0.01% 349
2015
Q2 		$13K Sell
405
-3
-0.7% -$93 ﹤0.01% 337
2015
Q1 		$12K Buy
408
+180
+79% +$5.16K ﹤0.01% 377
2014
Q4 		$6K Hold
228
– – ﹤0.01% 387
2014
Q3 		$5K Sell
228
-350
-61% -$8.01K ﹤0.01% 358
2014
Q2 		$13K Sell
578
-52,036
-99% -$1.21M ﹤0.01% 323
2014
Q1 		$1.33M Buy
+52,614
New +$1.33M 0.05% 174

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Smith Group Asset Management's EBS Position: Q3 2021 in Review

Smith Group Asset Management sold out of Emergent Biosolutions (EBS) in Q3 2021, closing a stake of 50 shares — an estimated $3K sold.

Smith Group Asset Management first reported a position in EBS in Q1 2014 and held it in 30 quarters. The position peaked at $1.33M in Q1 2014. 277 funds tracked by Wall St. Rank hold EBS as of Q3 2021.

  • Smith Group Asset Management reported no remaining Emergent Biosolutions position as of Q3 2021 after selling out during the quarter.
  • Smith Group Asset Management sold 50 Emergent Biosolutions shares in Q3 2021, an estimated $3K.
  • Smith Group Asset Management first reported a position in Emergent Biosolutions in Q1 2014 and held it in 30 quarters.
  • Smith Group Asset Management's Emergent Biosolutions position peaked at $1.33M in Q1 2014.
  • 277 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2021.

Based on Smith Group Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.